Delivery Order SPE2DB25D9336-SPE2DB25FPARC
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $13,844.40, is for the delivery of BOTOX 100 unit vials and has an ultimate completion date of September 4, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999, that allows the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,587.40 by the Defense Logistics Agency (DLA) on August 14, 2025, for the supply of Botox 200 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 5, 2025, and was awarded without any set-aside designation. Performance will take place at the vendor's Park Ridge, Illinois location....
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,293.72 contract is for the delivery of 200 unit vials of the pharmaceutical product BOTOX. This order is placed under a larger five-year, $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA to provide a wide range of pharmaceutical products...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $2,768.88 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 100-unit vials of BOTOX to fulfill the medical supply needs of military health facilities supported by DLA. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with the DLA, valued at up to...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,775.42 by the Defense Logistics Agency on August 28, 2025, for the supply of Botox 100 Unit Vials. The contract carries a firm fixed-price structure with an ultimate completion date of September 19, 2025, and was executed with no set-aside designation. Performance will occur at the contractor's facility in Park Ridge, Illinois. This...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,785.00 contract is for the delivery of Botox Cosmetic 50 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) valued at up to $499,999,999 held by DMS...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,537.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Botox 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $11,537.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 100-unit vials of the pharmaceutical drug Botox with a completion date of July 23, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,319.49, is for the provision of 4,559,056,548 units of Botox 100-unit vials. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, that runs through December 31,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $46,148.00, is for the delivery of 100-unit vials of the drug Botox with a completion date of May 14, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group Inc., valued at up to $499,999,999, that allows...
- SPE2DB25D9336Indefinite Delivery Contract
- SPE2DB25D9336-SPE2DB25FPARCDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 25, 2025, for BOTOX 200 unit vials under a firm fixed-price contract with a ceiling value of $2,587.40. The award was issued by the Defense Logistics Agency (DLA), a defense organization responsible for supplying the Department of Defense with critical materials and services. The contract type reflects a delivery order issued against a larger indefinite delivery contract vehicle, with no set-aside designation applied, and includes an ultimate completion date of September 16, 2025. The place of performance is located in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's larger DLA Indefinite Delivery Contract valued at $499,999,999 and valid through November 2026, which enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. The company's federal contract portfolio demonstrates consistent success in supplying specialty pharmaceutical products, including biologics, prescription medications, and medical consumables to Department of Defense healthcare sites. The DLA's pharmaceutical procurement through this vehicle supports the medical supply needs of military treatment facilities and ensures reliable distribution of critical medications and injectable products across the federal healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/25/25 |